Abstract:Achieved herein is a novel diversity‐oriented one‐pot multicomponent synthesis of polycyclic pyrrolidinyl‐dispirooxindoles 3. The key pyrrolidine forming reaction is the 1,3‐dipolar cycloaddition event of isatylidenyl‐chromanones 2 with azomethine ylides (thermally generated in situ from isatins and proline or thioproline). Products bearing four consecutive stereocenters consist of two oxindole moieties and a pyrrolidinyl core, including vicinal spiroquaternary stereocenters fused in one ring structure, were smoothly obtained in high yields (up to 89% yield) with good diastereoselectivity (up to >20:1). Valuable feature of this method was the design of new hybrid architectures for biological screenings through creating molecular diversity and complexity by means of the generation of several bonds and rings in a single operation. In particular, their biological activity against human leukemia cells K562 and normal L929 cells have been evaluated. These results suggested changes of this chromanone group could obviously impact the activity, and a chromanone group located in the polycyclic pyrrolidinyl‐dispirooxindoles is beneficial for the activity. What is more, the results also indicated that chromanone‐fused polycyclic pyrrolidinyl‐dispirooxindoles 3 have selective cytotoxicity against cancer cells K562 compared with normal cells L929.

Diversity-oriented TsOH Catalysis-Enabled Construction of Tanshinone-Substituted Bis(indolyl/pyrrolyl)methanes and Their Biological Evaluation for Anticancer Activities

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[Indol-3-yl-methylene]-1h-pyrazol-5(4h)-one Derivatives

Construction of Turmerone Motif-Fused Spiropyrrolidine Oxindoles and Their Biological Evaluation for Anticancer Activities

Molecular Hybridization-Guided 1,3-Dipolar Cycloaddition Reaction Enabled Pyrimidine-Fused Spiropyrrolidine Oxindoles Synthesis As Potential Anticancer Agents

Diversity-oriented One-Pot Multicomponent Synthesis of Spirooxindole Derivatives and Their Biological Evaluation for Anticancer Activities

A Library of 1,2,3-Triazole-substituted Oleanolic Acid Derivatives As Anticancer Agents: Design, Synthesis, and Biological Evaluation

Diversity‐oriented Construction of Chromanone‐fused Polycyclic Pyrrolidinyl‐dispirooxindoles

Synthesis and in Vitro Evaluation of Pyrimidine-Fused 3-Alkenyloxindoles As Potential Anticancer Agents

Et2NH Catalysis-Enabled Construction of Convolutamydine A-fused Morusignin L-scaffolds and Their Biological Evaluation for Anticancer Activities

Diversity‐Oriented Synthesis of Functionalized Imidazopyridine Analogues with Anti‐Cancer Activity Through a Transition‐Metal Free, One‐pot Cascade Reaction

Design, Synthesis and Biological Evaluation of Novel Antitumor Spirodihydrothiopyran-Oxindole Derivatives

Synthesis and Antitumor Activities of Novel Pyrimidine-fused Spiropyrrolidine Oxindoles

Design, Synthesis and Evaluation of Structurally Diverse Polycyclic Harmaline Scaffolds As Anticancer Agents

Regio- and stereoselective synthesis and evaluation of densely functionalized bispiro[oxindole-isoxazole-indandione] hybrids as anticancer agents

Rapid Assembly of 1,3-Indanedione-based Spirocyclic Tetrahydroquinolines for Inducing Human Lung Cancer Cell Apoptosis

Design, Synthesis and Biological Evaluation of Novel Antitumor Spirotetrahydrothiopyran-Oxindole Derivatives As Potent P53-Mdm2 Inhibitors

Construction of Diversified Penta-spiro-heterocyclic and Fused-heterocyclic Frameworks with Potent Antitumor Activity.

Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities

A Facile and Efficient Synthesis of Hexahydro-1H-pyrido[2,3-b]indol-2-one Scaffolds Via a Sequential Michael Addition/amidation/reductive Cyclization Process

Synthesis of spiro-tetrahydrothiopyran-oxindoles by Michael–aldol cascade reactions: discovery of potential P53-MDM2 inhibitors with good antitumor activity

Design, Synthesis and Evaluation of Structurally Diverse Ortho-Acylphenol-diindolylmethane Hybrids As Anticancer Agents